U.S. Court of Appeals for the Federal Circuit, 2016

Andrulis Pharmaceuticals Corp. v. Celgene Corporation

Andrulis Pharmaceuticals Corp. v. Celgene Corporation
U.S. Court of Appeals for the Federal Circuit · Decided July 14, 2016

Andrulis Pharmaceuticals Corp. v. Celgene Corporation

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ ANDRULIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellant v. CELGENE CORPORATION, Defendant-Appellee ______________________ 2015-1962 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:13-cv-01644-RGA, Judge Richard G. Andrews. ______________________ JUDGMENT ______________________ ELIOT JAMES WALKER, Skiermont Derby LLP, Dallas, TX, argued for plaintiff-appellant. Also represented by PAUL SKIERMONT, STEVEN UDICK, SARAH ELIZABETH SPIRES.

CALVIN P. GRIFFITH, Jones Day, Cleveland, OH, ar- gued for defendant-appellee. Also represented by JOHN CHARLES EVANS; ANTHONY M. INSOGNA, San Diego, CA; JENNIFER LORAINE SWIZE, DANIEL KAZHDAN, Washington, DC. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (PROST, Chief Judge, SCHALL and CHEN, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

July 14, 2016 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.